Ascendis Health (ASC) – Under Pressure

YTD ASC’s share price has declined by c.40% on the back of high debt levels and issues surrounding the organic sales growth. We are pleased by ASC attempts at managing its debt levels, we are however concerned about the ongoing challenges within the Consumer Brands division which we believe will persist putting pressure on organic sales growth.